/term/bs-unearned-income/TSX:ASP Acerus Pharmaceuticals (TSX:ASP) Unearned Income
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Unearned Income

Acerus Pharmaceuticals (TSX:ASP) Unearned Income


View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Unearned Income?

Unearned Income only applies to banks.

Acerus Pharmaceuticals (TSX:ASP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Unearned Income
Comparable Companies
TSXV:NDVA TSX:AH XCNQ:LOWL TSX:NEPT XCNQ:VEXT TSX:WLLW TSXV:KHRN TSX:DN TSXV:DB XCNQ:TRIP XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8
Website
https://www.aceruspharma.com
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Executives
Norma Beauchamp Director
Stephen Robert Gregory Director
Edward Joseph Gudaitis Director, Senior Officer